Robert Bruce's OGN Position Overview
Robert Bruce (via Bruce & Co., Inc.) currently holds 31.2K shares of Organon & Co. (OGN) worth $0, representing 0.00% of the portfolio. First purchased in 2021-Q3, this medium-term investment has been held for 16 quarters.
Based on 13F filings, Robert Bruce has maintained a strategic position in OGN, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2024, adding 180 shares. Largest reduction occurred in Q4 2022, reducing 500 shares.
Analysis based on 13F filings available since 2013 Q2
Robert Bruce's Organon & Co (OGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Organon & Co (OGN) Trades by Robert Bruce
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2021 | +32,370 | New Buy | 32,370 | $32.78 |
| Q1 2022 | -400 | Reduce 1.24% | 31,970 | $34.91 |
| Q4 2022 | -500 | Reduce 1.56% | 31,470 | $27.93 |
| Q3 2023 | -280 | Reduce 0.89% | 31,190 | $17.36 |
| Q2 2024 | +180 | Add 0.58% | 31,370 | $20.70 |
| Q4 2024 | -170 | Reduce 0.54% | 31,200 | $14.92 |
| Q2 2025 | -31,200 | Sold Out | 31,200 | $0.00 |
Robert Bruce's Organon & Co Investment FAQs
Robert Bruce first purchased Organon & Co. (OGN) in Q3 2021, acquiring 32,370 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Bruce has held Organon & Co. (OGN) for 16 quarters since Q3 2021. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Bruce's largest addition to Organon & Co. (OGN) was in Q3 2021, adding 32,370 shares worth $1.06 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q2 2025, Robert Bruce's firm, Bruce & Co., Inc., owns 31,200 shares of Organon & Co. (OGN), valued at approximately $0. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q2 2025 filing, Organon & Co. (OGN) represents approximately 0.00% of Robert Bruce's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Bruce's peak holding in Organon & Co. (OGN) was 32,370 shares, as reported at the end of Q3 2021. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.